Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dasatinib
Related studies linked through entity extraction aliases.
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- PHASE3
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
- Status
- TERMINATED
- Phase
- PHASE1
TORI 104 Pre-Surgical Dasatinib
- Status
- WITHDRAWN
- Phase
- PHASE2
Effects of Gastric pH on the Pharmacokinetics of Dasatinib
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
- Status
- COMPLETED
- Phase
- PHASE2